K. Rivet Amico, PhD
About K. Rivet Amico, PhD
Rivet is a research scientist at the University of Connecticut’s Center for Health, Innovation, and Prevention, and also works with Applied Health Research as a developer and trainer of interventions that use communication and counseling theory to support adherence and retention in the context of clinical trials and resource limited settings.
Methodology, design, measurement, and analytic strategies in cross-sectional and longitudinal designs are also of interest. The development of interventions to support medication and treatment adherence that are ecologically valid, culturally competent, and highly translatable to practical settings guides much of my research and project development to date. As a co-developer of the IMB-model of HAART adherence and the developer of the situated-Information Motivation Behavioral Skills model of care initiation and maintenance (sIMB-CIM), Rivey firmly believes in the potential contributions that theorists and methodologists can make in efforts to promote health behavior. The intersection between medicine, behavioral science, and systems of care offers the unique opportunity for health psychologists to actively contribute to multidisciplinary teams and shape the direction of behavioral interventions for promotion of health and clinical outcomes for those struggling with chronic medical conditions. This is particularly the case in HIV care, as this cohort is aging and the proportion of those dealing with co-morbities continues to increase. Similarly, in areas where diet and lifestyle are the targets of recommended treatment, sophisticated strategies for supporting engagement in care must address broad compendiums of treatment recommendations and not just adherence to medication. It is in these areas that my program of research seeks to develop and evaluate comprehensive models and model-based interventions.
Role(s) / Profession(s)
- Researcher
Organization
- University of Connecticut
Work Location(s)
- United States
K. Rivet's Communities
- Adherence & Retention Moderator
- HIV Prevention
Language(s)
- English
- French
Recent Contributions
-
K. Rivet Amico, PhD replied to "Indus Hospital's MDR TB Program in the New York Times" in the MDR-TB Treatment & Prevention community.
Wonderful moving coverage of a terrible situation and the critical work going on to address it in Pakistan. Thank you for the link! Rivet Amico University of Connecticut
-
K. Rivet Amico, PhD replied to "Working Paper on HIV/AIDS Care in resource poor settings: Optimizing delivery for adherence" in the Adherence & Retention community.
A great call for the need for integrated intervention/prevention approaches! I would add to this list, strategies to promote risk reduction within cohorts who are positive and other self-care/health protective behaviors (as well noted, adherence to ARVs, but also adherence to other treatment recommendations- e.g., early enrollment into care, retention over time) within the compendium of services to best facilitate use of services as they become available/accessible. Thanks for sharing this work!
-
K. Rivet Amico, PhD replied to "Cost-effectiveness of adherence interventions in resource-poor countries?" in the Adherence & Retention community.
I think cost effectiveness and demonstration studies in general have received less attention than needed in this area-- thus cost effectiveness if often guess work when moving from a RCT to real world applications. This, coupled with what you have already noted in terms of a need for more research establishing adherence interventions that are effective in resource-constrained and diverse cultural settings, makes determining which interventions are both demonstrated and cost effective in a given ...
-
K. Rivet Amico, PhD replied to "Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials" in the Adherence & Retention community.
Ann's comments here are really important. While we are all interested in finding a strategy that works, finding one that works for everyone equally well may be an oversimplification. What works, for whom, when is likely the better question. We need the meta work and the large trials to provide empirical guidance. Research of this kind helps to answer- What is likely or unlikely to work well, globally (in general and in comparison to something). ...
-
K. Rivet Amico, PhD replied to "linkage to and retention in care" in the Adherence & Retention community.
Jessica, Our group is working on a model drawing from the Information, Motivation, Behavioral Skills model for HIV care initiation and maintenance and we've been gathering qualitative data in NY to inform the model (Laramie Smith will be presenting her results on this at IAPAC this year). To get interviews with people tenuously engaged in care, she frequently went out to transient housing and parks. But that was in NY with the collaboration of outreach ...
Recent Recommendations
- None at this time.